GISELLA GUICHARD: Open Payments
NPI 1437747763 · ROSLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$832 in 37 payments from 13 companies in 2025. Trend: 2023 $602 · 2024 $758 · 2025 $832
Food & beverage: $832
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 6 | $107 |
| Novartis Pharmaceuticals Corporation | 6 | $106 |
| Novo Nordisk Inc | 4 | $97 |
| United Therapeutics Corporation | 3 | $90 |
| Esperion Therapeutics, Inc. | 4 | $78 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $77 |
| CVRx, Inc. | 1 | $67 |
| Amgen Inc. | 3 | $62 |
| Boston Scientific Corporation | 2 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
Products named: VERQUVO, LEQVIO, NEXLETOL, JARDIANCE, Barostim Neo System, REPATHA, Tyvaso, WATCHMAN FLX.
Industry payments across NY — which companies pay providers there.
